Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliar
- This topic has 0 replies, 1 voice, and was last updated 3 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study
https://pubmed.ncbi.nlm.nih.gov/32517311/?from_term=cholangiocarcinoma&from_sort=date&from_pos=2
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.